E1 and G1

DRUG2 trials

Sponsors

OPKO Health, Inc.

Conditions

Type 1 DiabetesType 2 Diabetes

Phase 1

A Study in Type 2 Diabetic Patients With Repeated Doses of E1 in Combination With G1

CompletedNCT00239187

OPKO Health, Inc.Type 2 Diabetes

Start: 2005-09-30End: 2007-01-31Target: 30Updated: 2019-10-18

A Study in Type 1 Diabetic Patients With Repeated Doses of E1 in Combination With G1

CompletedNCT00239148

OPKO Health, Inc.Type 1 Diabetes

Start: 2005-06-30End: 2006-12-31Target: 20Updated: 2019-10-18